Covira Surgical, Inc.
Biotechnology company · North Chicago, Illinois, United States
Covira Surgical, Inc. is a biotechnology company headquartered in North Chicago, Illinois, United States. Its earliest recorded incorporation is in 2018. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.7 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $275,000 sold in a notice filed in 2022.
Covira Surgical at a glance
What does Covira Surgical do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.7 million in total (2023 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $275,000 sold (2022).
Frequently asked questions about Covira Surgical
Where is Covira Surgical headquartered?
Covira Surgical, Inc. is headquartered in North Chicago, Illinois, United States.
What does Covira Surgical do?
Covira Surgical, Inc. is a biotechnology company.
When was Covira Surgical founded?
The earliest incorporation on record for Covira Surgical, Inc. is in 2018, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences